Morphic Holding Inc (MORF)
29.25
-3.20
(-9.86%)
USD |
NASDAQ |
May 17, 16:00
29.25
0.00 (0.00%)
After-Hours: 20:00
Morphic Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | 68.95M |
| December 31, 2022 | 70.81M |
| September 30, 2022 | 74.23M |
| June 30, 2022 | 75.30M |
| March 31, 2022 | 18.91M |
| December 31, 2021 | 19.79M |
| September 30, 2021 | 16.14M |
| June 30, 2021 | 38.77M |
| Date | Value |
|---|---|
| March 31, 2021 | 42.62M |
| December 31, 2020 | 44.94M |
| September 30, 2020 | 38.71M |
| June 30, 2020 | 18.63M |
| March 31, 2020 | 16.50M |
| December 31, 2019 | 16.98M |
| September 30, 2019 | 20.67M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
16.14M
Minimum
Sep 2021
75.30M
Maximum
Jun 2022
38.80M
Average
38.71M
Median
Sep 2020
Revenue (TTM) Benchmarks
| Keros Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.23M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |